b'u From Page 1875.7% to 82.2%, and for those hospitalized for acute complica-tions, 58.3% to 66.4%, over the period of hospitalization. Multiple assessments of CGM systemsduringthepandemic determined that the technology provided accurate data and could beusedforclinicaldecision-makingandinsulintitration, thoughnursesreporteddissat-isfaction with the length of time spent in a protocol designed to verifyaccuracythatrequired simultaneoususeofCGMand usual care. Nearly two-thirds of nurses found the system helpful for managing clinical care, with studies indicating a reduction in point of care assessment of 50%Source: Gothong C, Singh LG, Satyarengga M, Spanakis EK. Continuous glucose monitoring in the hospital: to 63% and concomitant reduc- an update in the era of COVID-19. Curr Opin Endocrinol Diabetes Obes. 2022 Feb 1;29(1):1-9. doi: tion in use of personal protective10.1097/MED.0000000000000693. PMID: 34845159; PMCID: PMC8711300.equipment.TheBaltimoreteamcomparedthetransitiontosex,serumcreatinine,steroiddosing,renalfunc-CGM to the move from serum blood glucose to pointtion, diabetes type, response to insulin and estimated of care testing with glucometers. Just as glucometersresidual extracellular insulin. 3 have become the standard of care in recent decades,Theresearchteam,ledbyMadelineBrown, we believe that CGM devices will eventually be uti- PharmD, found that patients in the electronic system lized in the hospital as standard of care as they providegroup had fewer hypoglycemic events. The authors a more robust and enriched data set of glycemic val- concluded that eGMS use has the potential to mini-ues than glucometers, helping clinicians and nurses tomizehypoglycemiaandglycemicvariabilityina safely manage patients with diabetes without increas- criticallyillveteranpopulationbyindividualizing ingworkload,theysaid.Inconclusion,althoughinsulin drip titration based on a variety of patient-CGM devices are currently seen as novel systems, itspecific factors and providing reminders for staff to is only a matter of time when CGM systems will beobtain [blood glucose] checks in a timely manner.approved for use in the inpatient setting. 1Gothong C, Singh LG, Satyarengga M, Spanakis EK. Continuous Another VA study looked at the use of an electronicglucose monitoring in the hospital: an update in the era of COVID-19. glucosemonitoringsystem(eGMS)comparedtoCurr Opin Endocrinol Diabetes Obes. 2022 Feb 1;29(1):1-9. doi: 10.1097/MED.0000000000000693. PMID: 34845159; PMCID: paper-based protocols for management of diabeticPMC8711300. ketoacidosis (DKA) and hyperglycemic hyperosmo- 2 Swanson C, Potter D, Kongable G, Cook C. Update on inpatient lar syndrome (HHS) in retrospective study of veter- glycemic control in hospitals in the United States. Endocrine Practice. ans treated in the emergency department of intensive2017;17:853861.care unit at Veteran Health Indiana. Paper-based sys- 3Brown M, Roberts J, Smith C, Eash D. Safety and Effectiveness of tems rely on patient weight to determine initial insu- the Use of an Electronic Glucose Monitoring System Versus Weight-lin drip rate and use a formula based on changes inBased Dosing Nomogram for Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome in a VA Hospital. blood glucose levels to adjust the drip. The electronicJ Diabetes Sci Technol. 2022 Feb 7:19322968221074710. doi: system adjusts doses by weight height, weight, age,10.1177/19322968221074710. Epub ahead of print. PMID: 35128975.20'